Latest Investor Confidence News

Eden Innovations has secured a $2.2 million strategic investment to fully repay its remaining iBorrow debt, eliminating costly interest payments and strengthening its balance sheet ahead of anticipated revenue growth.

Regal Partners anticipates a strong 2025 with normalised NPAT reaching $145 million, propelled by a significant jump in performance fees and funds under management climbing to $20.8 billion.

The Singapore International Commercial Court has dismissed Poland’s challenge to GreenX Metals’ £183 million Energy Charter Treaty compensation, reinforcing the company’s significant legal victory.

Skylark Minerals Limited has applied for ASX quotation of 37.98 million fully paid ordinary shares from a previously approved placement, signalling a key step in its capital expansion strategy.

Sprintex Limited has raised A$3.625 million through option exercises and a share placement, strengthening its balance sheet and accelerating growth following a landmark €15.6 million contract with Mest Water.

InhaleRx Limited has completed the final tranche of its share placement, raising $600,000 to support its clinical-stage drug development programs targeting pain and mental health.

Aristocrat Leisure has extended its on-market share buy-back program by an additional A$750 million, doubling the total capacity to A$1.5 billion as part of its ongoing capital management strategy.

Eastern Metals Limited will have its trading suspension lifted on 9 January 2026, marking its return to the ASX after meeting key listing requirements.

RocketBoots Limited has responded to ASX concerns over a delayed director interest disclosure, attributing the lapse to an administrative oversight during a holdings restructure. The company affirms its compliance policies and has taken steps to prevent future delays.

Imagion Biosystems has completed the conversion of its first tranche convertible notes with Mercer Street, issuing over 3 million shares, while renegotiating terms on the second tranche to extend maturity and reduce debt.

CurveBeam AI has received official Chinese regulatory approval for a strategic $10 million investment from WEGO Orthopaedics, marking a major step in its expansion into Greater China. The initial $4 million tranche at a premium share price is expected imminently, underpinning a decade-long commercialisation deal.

Mount Hope Mining Limited has explained the late lodgement of director interest disclosures as an administrative oversight, responding to ASX concerns over potential compliance breaches.